Avantor, Inc. (AVTR)

Market Cap	6.17B -59.3%
Revenue (ttm)	6.55B -3.4%
Net Income	-530.20M
EPS	-0.78
Shares Out	682.06M
PE Ratio	n/a
Forward PE	11.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,614,500
Open	9.02
Previous Close	9.20
Day's Range	8.97 - 9.22
52-Week Range	8.90 - 18.02
Beta	0.95
Analysts	Hold
Price Target	12.93 (+42.87%)
Earnings Date	Feb 11, 2026

About AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 17, 2019
• Employees: 13,500
• Stock Exchange: NYSE
• Ticker Symbol: AVTR
• Website: https://www.avantorsciences.com

Analyst Summary

According to 14 analysts, the average rating for AVTR stock is "Hold." The 12-month stock price target is $12.93, which is an increase of 42.87% from the latest price.

Price Target

$12.93

(42.87% upside)

Analyst Consensus: Hold